News for hackers. Stuff that matters.
Re:A Blue Pill Is Stopping HIV, World-First Study Shows by aerotwelve on Sunday October 21, 2018 @10:42PM (#18271781)
Serious question: what's the point of the sticker price then? Surely someone must be paying it, right?

If not, why not lower it for -- at a minimum -- a PR boost?

Re:A Blue Pill Is Stopping HIV, World-First Study Shows by pkaye on Monday October 22, 2018 @12:44AM (#18272232)
The manufacturer charges a higher price to the insurer and pays for the consumers copay so they are not impacted by price sensitivity. Kind of like business travels tend to spend more because it is the companies money vs their own. If the copay is too high, consumers might shop for cheaper alternatives instead of the "latest and best".
Re:A Blue Pill Is Stopping HIV, World-First Study Shows by barry-cotter on Sunday October 21, 2018 @11:18PM (#18271952)
The sticker price is negotiating leverage for use against organisations with money, the insurance companies and Medicaid and Medicare. They don’t pay the sticker price either but they come much closer because they’re price insensitive. All costs get passed on, on average to the actuarial customer.
Re:A Blue Pill Is Stopping HIV, World-First Study Shows by acct1771 on Monday October 22, 2018 @12:03PM (#18275806)
In addition to what other commenters have said, when you write off donated units, they're worth more at that time if their price is higher.
Re:A Blue Pill Is Stopping HIV, World-First Study Shows by brazzledazzle on Sunday October 21, 2018 @11:16PM (#18271936)
It might be used as a starting point for negotiation with private insurers.